Then, using cycloheximide (CHX) to inhibit protein synthesis, we observed by Western blot that CSNK2B degradation was significantly accelerated in meningioma cells with RACK1 knockdown, whereas degradation was significantly slowed in those cells overexpressing RACK1 (Figure 3d). The gene discussed is CSNK2B; the disease is meningioma.